...
首页> 外文期刊>International Journal of Biomedical Science >The effect of assisted reproductive technologies on gynecological cancer: Report of our experiences and literature review
【24h】

The effect of assisted reproductive technologies on gynecological cancer: Report of our experiences and literature review

机译:辅助生殖技术对妇科癌症的影响:我们的经验报告和文献综述

获取原文
获取原文并翻译 | 示例

摘要

Introduction: Infertility is as an important and common problem in couples necessitating assisted reproductive technology (ART) or drug therapy. Infertility is known as a risk factor for ovarian, breast and endometrial cancer. We aimed on evaluation of the history of primary infertility and previous ART in patients with the above-mentioned cancers. Material and method: In this retrospective study we evaluated all of the risk factors in patients with breast cancer, ovarian cancer and endometrial cancers who referred to the Gynecological Oncology Clinic in Shahid Sadoughi Hospital in Yazd, Iran from 2002 to 2012. We also investigated the history of primary infertility and ART in these patients before diagnosis of cancers. Results: We gathered data from 92 patients with endometrial cancer, 84 patients with advanced epithelial ovarian cancer and 113 patients with breast cancer. There was history of infertility in 39.1% of patients with endometrial cancer who were obese (body mass index, BMI>29) and in 18.8% of patients with endometrial cancer and normal body mass index (BMI=25-29). ART had been performed in 7.3% of all patients with endometrial cancer. In patients with epithelial ovarian cancer, infertility was diagnosed in 28.4% and ART applied in 14.1%. Clomiphene with or without HCG and HMG was the most common drug used for patients with ovarian cancer. In patients with breast cancer, there was infertility in 16.5% and ART performed in 7.3%. Conclusion: Although infertility was present as an important and fairly common risk factor in some patients with endometrial, ovarian and breast cancer, but some other factors may be more important, including age, BMI and the etiology of infertility. Finding the association between ART and gynecological cancers needs long cohort studies with follow-up of infertile women who get the ART or drug therapy for over 15-20 years. We think BMI and age (in addition to infertility and ART) are contributing factors for development of gynecological cancers.
机译:简介:不育是夫妻中需要辅助生殖技术(ART)或药物治疗的重要且普遍的问题。不孕症是卵巢癌,乳腺癌和子宫内膜癌的危险因素。我们旨在评估上述癌症患者的原发性不育史和先前的ART。材料和方法:在这项回顾性研究中,我们评估了2002年至2012年在伊朗亚兹德Shahid Sadoughi医院妇科肿瘤诊所就诊的乳腺癌,卵巢癌和子宫内膜癌患者的所有危险因素。我们还调查了在诊断出癌症之前,这些患者的原发性不育和ART史。结果:我们收集了来自92例子宫内膜癌,84例晚期上皮性卵巢癌和113例乳腺癌的数据。肥胖的子宫内膜癌患者中有39.1%(体重指数,BMI> 29)有不育史,子宫内膜癌且体重指数正常(BMI = 25-29)中有18.8%的妇女有不育史。 7.3%的子宫内膜癌患者接受了抗逆转录病毒疗法。在患有上皮性卵巢癌的患者中,诊断为不孕的占28.4%,应用抗逆转录病毒治疗的占14.1%。有或没有HCG和HMG的克罗米芬是用于卵巢癌患者的最常用药物。在乳腺癌患者中,不育症占16.5%,ART占7.3%。结论:尽管不孕症是某些子宫内膜癌,卵巢癌和乳腺癌患者的重要且相当普遍的危险因素,但其他一些因素可能更重要,包括年龄,BMI和不孕症的病因。要找到抗逆转录病毒疗法与妇科癌症之间的联系,需要进行长期的队列研究,并对接受抗逆转录病毒疗法或药物治疗超过15至20年的不育妇女进行随访。我们认为BMI和年龄(除了不孕症和抗逆转录病毒疗法)是妇科癌症发展的促成因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号